Innoviva Inc (INVA) earnings · P/E 4.8, rev $411.3M
These earnings events as JSON? API free 100/dayInnoviva Inc (INVA) is a biotechnology company listed on US.
This INVA earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported INVA revenue for 2025-12-31 was $411.3M. Net income was $271.2M. Revenue was up 14.7% from 2024-12-31 to 2025-12-31. INVA currently screens at market cap $1.66B and trailing P/E 4.8.
When the next INVA 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 14.7% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full INVA research stays on the stock page; the tape stays on the quote page.
INVA earnings FAQ
What are INVA's latest revenue and net income?
Latest cached Innoviva Inc (INVA) revenue for Dec 31, 2025 was $411.3M. Net income was $271.2M. Statements: https://lician.com/financials/inva
What is INVA's latest diluted EPS?
Latest cached Innoviva Inc (INVA) diluted EPS for Dec 31, 2025 was $3.30.
What period does the latest INVA earnings print cover?
The latest cached Innoviva Inc (INVA) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did INVA revenue change from the prior cached period?
Cached Innoviva Inc (INVA) revenue was up 14.7% from $358.7M (Dec 31, 2024) to $411.3M (Dec 31, 2025). Statements: https://lician.com/financials/inva
What is INVA's P/E ratio?
Innoviva Inc (INVA) trailing P/E is 4.82 on the latest cached fundamentals snapshot.
Where are INVA earnings listed?
Cached earnings facts for Innoviva Inc (INVA) are listed at https://lician.com/earnings/inva. Statements: https://lician.com/financials/inva
Not investment advice.